![Essential tools for wound care [Image designed by Freepik]](https://static.wixstatic.com/media/553507_373ac4add2a645b6afeafe8ab69e7df6~mv2.jpg/v1/fill/w_980,h_653,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/553507_373ac4add2a645b6afeafe8ab69e7df6~mv2.jpg)
Introduction
Haemostasis, the process that prevents and stops bleeding, is critical in various fields, particularly in medicine. With a growing demand for effective haemostatic agents, the exploration of biopolymers has gained traction. Among these biopolymers, chitin and chitosan, derived from natural sources, have emerged as promising candidates. This article will extensively discuss the haemostatic properties and applications of chitin and chitosan, particularly emphasising chitin derived from Black Soldier Flies (BSFs) over traditional crustacean sources.
What Are Chitin and Chitosan?
Chitin is a natural biopolymer found in the exoskeletons of insects, crustaceans, and fungi. It is the second most abundant biopolymer in nature, after cellulose. Chitosan is derived from chitin through deacetylation, a process that increases its solubility and enhances its bioactivity. Chitosan, being biodegradable, non-toxic, and biocompatible, has garnered significant interest in medical applications, especially in wound healing and drug delivery (Dai et al., 2011).
The Haemostatic Properties of Chitin and Chitosan
Mechanisms of Action

The ability of chitin and chitosan to promote haemostasis can be attributed to several mechanisms:
Adsorption of Proteins: Chitosan's cationic nature allows it to bind with negatively charged proteins in the blood, such as fibrinogen and platelets, thereby accelerating clot formation (Zhang et al., 2013).
Support for Platelet Aggregation: Chitosan enhances platelet adhesion and aggregation, crucial for the initial phases of wound healing. This interaction can help in forming a stable fibrin network essential for clot formation (Chou et al., 2003).
Release of Growth Factors: Chitosan has demonstrated properties that may lead to the controlled release of various growth factors, promoting tissue regeneration alongside haemostasis (Busilacchi et al., 2013).
Antimicrobial Activity: The antimicrobial properties of chitosan can prevent infections at the wound site, further supporting the healing process (Hosseinnejad & Jafari, 2016).
Comparative Advantages of Chitin and Chitosan from BSFs
While crustaceans have been the primary source of chitin and chitosan, BSFs present several advantages:
![The Black Soldier Fly (Hermetia illucens) [Image by Adobe Stock]](https://static.wixstatic.com/media/553507_f9f80fccf9ea4d64b5e2a2c5703d613c~mv2.jpeg/v1/fill/w_980,h_653,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/553507_f9f80fccf9ea4d64b5e2a2c5703d613c~mv2.jpeg)
Sustainability: BSFs can be reared on organic waste, making their cultivation environmentally friendly and sustainable. This contrasts with crustaceans, whose harvesting can lead to ecosystem and population imbalances (Siddiqui et al., 2022).
Lower Allergenic Potential: While it shares some similarities with crustacean-derived chitin, it lacks the specific proteins that often cause allergic reactions in shellfish-sensitive individuals. This makes it a safer option for medical applications, expanding its potential use without compromising efficacy (Bessa et al., 2021).
Economic Viability: BSF rearing for chitin production offers a compelling economic advantage. BSF farming requires minimal land and resources compared to crustacean harvesting. Additionally, the process generates valuable by-products like protein-rich insect meal and lipids, further enhancing profitability and reducing waste (Barragan-Fonseca et al., 2021).
Evidence Supporting the Haemostatic Efficacy of Chitosan
Numerous studies have demonstrated the effectiveness of chitosan as a haemostatic agent.
A study by (Wang et al., 2019) revealed that chitosan dressings had superior haemostatic properties to regular gauze-type surgical dressing. Chitosan dressing reduced the time to haemostasis and effectively mitigated blood loss and absorption in an animal model of femoral artery haemorrhage and in patients with surgical wounds.
Chitosan-coated sutures could significantly improve haemostasis in surgical applications, effectively minimizing post-operative complications due to its improved ability to control bleeding over traditional cotton gauze (Notario-Pérez et al., 2022).
These findings underscore the significant potential for chitosan to be integrated into haemostatic products across various medical settings. In fact, several leading wound care manufacturers already enrich their products with chitosan (see: @Steroplast Healthcare Limited's best-selling ChitoSAM range as an example)
Applications in the Medical Field
![Chitosan-based wound dressings offer a natural and effective solution for wound healing [Image by Zivica Kerkez, Adobe Stock]](https://static.wixstatic.com/media/553507_b320cf1c6d754918ad676a7bee14f7fe~mv2.jpeg/v1/fill/w_980,h_654,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/553507_b320cf1c6d754918ad676a7bee14f7fe~mv2.jpeg)
Wound Dressings
Chitosan-based wound dressings have become notable for their ability to promote rapid haemostasis. They serve not only as physical barriers to injury but also as active agents in the wound healing process. The porous structure of chitosan promotes moisture retention, facilitating a conducive healing environment (Jayakumar et al., 2011).
Surgical Applications
Chitosan has found its way into surgical settings where rapid haemostasis is crucial. Surgical sponges and hemostatic agents constructed from chitosan expedite the clotting process and are increasingly adopted due to their biocompatibility and ease of integration into tissues (Notario-Pérez et al., 2022).
Drug Delivery Systems
Chitosan's biocompatibility and ability to encapsulate drugs effectively enable its use in controlled drug delivery systems. Its biodegradable nature allows for the gradual release of therapeutic agents beneficial in post-surgical recovery and infection prevention (Bernkop-Schnürch & Dünnhaupt, 2012). The natural properties of chitosan facilitate the delivery of anti-inflammatory and antimicrobial drugs, enhancing patient outcomes and minimizing side effects.
Bone Regeneration
Chitosan's ability to promote cell proliferation and differentiation makes it a suitable candidate for bone regeneration applications. Studies have shown that chitosan scaffolds can support osteoblast activity, thus facilitating bone tissue regeneration (Tao et al., 2020). Its biocompatibility and bioactivity are critical in developing advanced bone graft materials that promote healing and integration with host tissues.
Veterinary Medicine
The versatility of chitosan extends into veterinary medicine, where its haemostatic properties contribute to animal health. Chitosan-based products have been utilized in surgical procedures and wound care for animals, promoting healing and reducing recovery times (Şenel & McClure, 2004). With its sustainable sourcing from BSFs, chitosan presents a viable option for veterinary practitioners seeking effective treatment solutions.
Regulatory Considerations
As chitin and chitosan gain traction in medical applications, regulatory bodies are increasingly scrutinising their use. In the United States, the Food and Drug Administration (FDA) has recognized chitosan as Generally Recognized As Safe (GRAS), facilitating its incorporation into medical devices and products. Furthermore, the European Medicines Agency (EMA) provides guidelines for the use of these biopolymers in medicinal applications, ensuring that products meet safety and efficacy standards.
Future Perspectives
The future of chitin and chitosan in haemostasis and medical applications appears promising. As research continues to unveil new properties and applications of these biopolymers, we can anticipate innovations that enhance their effectiveness and broaden their uses. The integration of advanced technologies, such as 3D printing, could lead to the development of customized chitosan-based solutions for wound management and surgical applications.
Moreover, as the demand for sustainable materials in the medical industry grows, sourcing chitin from BSFs presents a compelling solution that aligns with ecological and ethical considerations. Entoplast is positioned to champion this shift, providing high-quality chitin and chitosan products that meet the evolving needs of the medical community.
Conclusion
In conclusion, the haemostatic properties of chitin and chitosan, particularly from Black Soldier Flies, present a ground breaking opportunity for revolutionising wound care and surgical procedures. With evidence supporting their efficacy, a sustainable production model, and a lower risk of allergenicity, these biopolymers represent the future of medical materials. The expanding applications of chitin and chitosan underscore their versatility and adaptability in addressing the complex challenges within the medical field.
As the industry moves toward sustainable and effective solutions, Entoplast is proud to be at the forefront, providing innovative chitin and chitosan offerings for your haemostatic needs. For more information on how our products can support your medical applications, contact a team member at hello@entoplast.com.
Comments